IntelliPharmaCeutics International Inc. (IPCI)
-NasdaqCM 1.84 
0.03(1.72%) 3:33PM EDT
| Prev Close: | 1.81 |
|---|
| Open: | 1.77 |
|---|
| Bid: | 1.34 x 100 |
|---|
| Ask: | 4.50 x 200 |
|---|
| 1y Target Est: | 6.38 |
|---|
| Beta: | 0.89 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.77 - 1.84 |
|---|
| 52wk Range: | 1.57 - 3.49 |
|---|
| Volume: | 10,647 |
|---|
| Avg Vol (3m): | 32,370 |
|---|
| Market Cap: | 36.29M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.31 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare ConferenceGlobeNewswire(Wed, Apr 24)
- Intellipharmaceutics Announces First Quarter 2013 ResultsGlobeNewswire(Wed, Apr 3)
- Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of UnitsGlobeNewswire(Mon, Mar 25)
- Intellipharmaceutics to Raise US$3.1 MillionGlobeNewswire(Tue, Mar 19)
- Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)GlobeNewswire(Wed, Mar 13)
- INTELLIPHARMACEUTICS INTERNATIONAL INC. FinancialsEDGAR Online Financials(Thu, Feb 7)
- Small Pharma Watch List: Week Of January 21stat Seeking Alpha(Tue, Jan 22)
- Intellipharmaceutics announces results of Phase I Pregabalin trialtheflyonthewall.com(Tue, Nov 27)
- 3 Dirt Cheap Drug Companies About To Make A Comebackat Seeking Alpha(Tue, Nov 6)
- Taking Note Of IntelliPharmaCeutics' Now Imminent FDA Decisionat Seeking Alpha(Mon, Oct 8)
- Intellipharmaceutics: Drug Delivery Specialist With Potential FDA Approval And Partnership Catalystsat Seeking Alpha(Thu, Aug 30)
- The Bio Pharma Momentum Movers List For Thursday, June 21at Seeking Alpha(Thu, Jun 21)
Key Statistics
| Forward P/E (1 yr): | 4.38 |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Nov-13)
: | -0.28 |
|---|
| Quarterly EPS Est
(May-13)
: | -0.12 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada.
View More